Still expensive, but a solution is within reach
08/10/19 -"According the press, an out of court settlement for all Glyphosat-based cases seems now to be on Mr Baumann's agenda. Having lost the three original cases in the US, the idea of settling all of them ..."
Pages
71
Language
English
Published on
08/10/19
You may also be interested by these reports :
12/12/25
Eli Lilly’s Retatrutide grabbed headlines with c.29% weight-loss efficacy in late-stage trials for obese patients who also had knee osteoarthritis. ...
08/12/25
Despite US tariff threats, drug pricing pressures and the persistent insistence from the US government to reshore manufacturing, the AV Big Pharmas ...
05/12/25
Against the backdrop of strong execution, with two outlook upgrades in 2025, backed by vigorous growth across all its focus areas (oncology, ...
28/11/25
Novo’s investors losing more weight than its patients